Standards & Regulation

Get a sharp perspective on the cell and gene status quo in The Medicine Maker 2022 supplement on advanced medicine

After years of progress in the courts, could one verdict in California give unproven stem cell clinics an unwelcome boost?

How a new working group plans to overcome the problem with in vitro pharmacology data.

Unregulated drugs being sold and distributed by the online retailer come under fire.

Substandard and falsified medicines are a global threat, but a collective pushback can beat them

Cytiva is working to address increasing demand for flexibility and component interchangeability.

From chasing drug lords to advising US presidents, it’s fair to say Robert Pinco has enjoyed a varied career.

Can blood cancer care be improved to ensure that patients from minority groups receive equitable treatment?

The women’s health treatment landscape is devoid of relevant options. What can pharma do to improve the situation?

ISCT speaks out after US court rules that stem cell therapy does not fall under FDA jurisdiction.